All microscopy was done at the W. M. Keck Microscopy Center with support of Nathaniel Peters and with support of NIH award S10OD016240. S.L.F. is supported by NIH K08AI119142 and R21AI130281. We thank Dr. Richard Flavell and Dr. Brad Cookson for caspase-1/11 deficient mice, and Dr. Brad Cookson for sharing laboratory facilities and equipment.

All animal procedures were approved and conducted under University of Washington Institutional Animal Care and Use Committee guidelines.
1. Harvest of Bone Marrow
<ol>
	<li>Aseptically remove the femur and tibia from a mouse and clean the bones using sterile instruments. Place the cleaned bones in Dulbecco Modified Eagle Medium (DMEM) + 5 mM HEPES + 0.2 mg/mL L-glutamine + 0.05 mM 2-mercaptoethanol + 50 mg/mL gentamicin sulfate + 10,000 U/mL penicillin/streptomycin + 10% fetal bovine serum (FBS, DMEM-10 complete) and incubate the tube on ice for 15 min.</li>
	<li>Remove the proximal and distal ball joints using scissors. Insert a 25 G needle attached to a 10 mL syringe filled with medium into the hollow of the bones. Flush out the bone marrow using DMEM-10 complete. Resuspend any clumps by pipetting the medium up and down gently.</li>
	<li>Centrifuge the cells for 10 min at 300 x g and count the number of cells using a hemocytometer. At this point, either freeze the cells using 90% FBS + 10% dimethyl sulfoxide (DMSO) or plate the cells in a 15 cm Petri dish to differentiate macrophages using L929 conditioned medium (step 2.1).</li>
</ol>
2. Differentiation of Bone Marrow-derived Macrophages
<ol>
	<li>Using pre-warmed differentiation medium (21 mL of DMEM-10 complete and 9 mL of L929 cell conditioned medium as described by Swanson et al.18), put bone marrow cells in a 15 cm non-tissue culture treated Petri dish (1.2-1.5 x 107 cells). Incubate the plate at 37 &#176;C and 5% CO2 for 7 days. Add an additional 30 mL of differentiation medium to the plate at day 3 or 4. 
	NOTE: It is important not to use tissue culture treated plates, as macrophages will be difficult to detach and harvest.</li>
	<li>To collect macrophages, wash the plate with phosphate-buffered saline (PBS) and add 20 mL of cold PBS + 1 mM ethylenediaminetetraacetic acid (EDTA). Incubate the plate at 4 &#176;C for 10 min. Harvest the cells by pipetting the PBS + EDTA over the cells and wash the plate with 10 mL of PBS. Combine both washes into two 15 mL conical tubes.</li>
	<li>Centrifuge the cells at 300 x g for 10 min and resuspend the cells in 10 mL of phenol-red free DMEM + 5 mM HEPES + 0.2 mg/mL L-glutamine + 0.05 mM 2-mercaptoethanol + 5% FBS (DMEM-5) and count the cells using either a hemocytometer or a Coulter counter. Keep the cells on ice during the counting.</li>
	<li>Seed the macrophages in tissue culture coated plates at 2 x 105 cells/mL. For microscopy experiments, seed 1 mL of cells on coverslips in 24 well plates. For LDH release assays, seed 100 &#181;L of cells in a 96 well plate. For the LDH assay, seed 9 wells (3 wells untreated, 3 wells with 100% lysis controls and 3 wells for the experimental stimulus).</li>
	<li>Centrifuge the 96 well plate for 5 min at 300 x g to make certain the cells are equally distributed across the well.</li>
	<li>Incubate the plate overnight at 37 &#176;C + 5% CO2 before starting the priming process.</li>
</ol>
3. Priming
<ol>
	<li>Replace the medium with fresh medium (DMEM-5) containing 100 ng/mL LPS (500 &#956;L for the 24 well plate or 50 &#956;L for the 96 well plate). 
	NOTE: There are a variety of structural variations in LPS, which affect the ability to stimulate TLR4-mediated priming19. LPS from Salmonella minnesota R595 (Re) is available from multiple vendors and is recommended.</li>
	<li>Incubate the plate for 3 h at 37 &#176;C and 5% CO2.</li>
</ol>
4. Activation of the NLRP3 Inflammasome with Nigericin and Labeling with FAM-YVAD-FMK
<ol>
	<li>Remove the medium and replace it with 290 &#956;L of DMEM-5 containing 5 &#956;M nigericin and 5 mM glycine. Glycine is added to reduce the amount of cell lysis that occurs during caspase-1 activation5. Incubate for 60 min at 37 &#176;C and 5% CO2. Use both wild type and caspase-1 deficient macrophages to ensure that the observed labeling is specific for caspase-1.</li>
	<li>During the last 45 min, add 10 &#956;L of 30x FAM-YVAD-FMK, prepared according to the manufacturer&#39;s instructions.</li>
	<li>After 60 min, remove the medium and wash the cells three times for 5 min each with 1 mL of cold PBS.</li>
	<li>Add 250 &#956;L of 2% paraformaldehyde to each well and incubate on ice covered with aluminum foil for 30 min.</li>
	<li>During the last 5 min, add 4 &#956;L of 0.2 mM far-red fluorescent nucleic acid stain to label the nuclei. 4&#39;,6-diamidino-2-phenylindole (DAPI) or other dyes can also be used to label DNA.</li>
	<li>Wash the cells three times with 1 mL of cold PBS and mount the coverslips onto microscope slides using 7 &#956;L anti-fade mounting medium. Let the mounting medium harden over night before sealing the coverslip to the microscope slide using nail polish.</li>
	<li>Image the macrophages by confocal microscopy. Ex/Em for FAM-YVAD-FMK is 492/520nm and 642/661 for far-red fluorescent nucleic acid stain. Make sure to set up the microscope such that untreated cells do not show any background staining in the 488 channel. Otherwise, background FAM-YVAD-FMK staining will be detected and not actual active caspase-1. 
	NOTE: Microscope set-up is described in section 6.</li>
</ol>
5. Antibody Staining
NOTE: To label the cells with antibodies to detect ASC, seed, prime and expose the cells to nigericin identical to the previous section. The processing afterwards is as follows:
<ol>
	<li>Wash the cells three times for 5 min each with 1 mL of cold PBS. Add 250 &#956;L of fixation and permeabilization solution. Incubate the cells on ice, and covered for 30 min.</li>
	<li>Wash the macrophages three times for 5 min each with 1 mL of wash buffer.</li>
	<li>Add 250 &#956;L of primary antibody against ASC diluted 1:500 in wash buffer and incubate for 1 h on ice. Include one coverslip that does not receive any primary antibody, but will only receive the secondary. This coverslip will be used during the microscope setup to set the correct offset.</li>
	<li>Wash the cells three times for 5 min each with 1 mL wash buffer.</li>
	<li>Add 250 &#956;L of secondary antibody (fluorescent dye conjugated goat-anti-mouse) diluted 1:500 in wash buffer and incubate for 1 h on ice. Add 4 &#956;L of 0.2 mM far-red fluorescent nucleic acid stain for the last 5 min of this incubation to label nuclei.</li>
	<li>Wash the cells 3x with 1 mL of cold wash buffer and mount the coverslips onto microscope slides using 7 &#956;L anti-fade mounting medium. Let the mounting medium harden over night before sealing the coverslip to the microscope slide using clear nail polish.</li>
	<li>Image macrophages by confocal microscopy. Ex/Em for the secondary antibody is 555/580 nm and 642/661 for far-red fluorescent nucleic acid stain (as described below). 
	NOTE: Labeling with FAM-YVAD-FMK and antibody labeling can be combined to show co-localization of active caspase-1 and ASC. For this, follow the conditions for FAM-YVAD-FMK labeling and then switch to the antibody labeling protocol for further processing.</li>
</ol>
6. Imaging of Labeled Macrophages by Confocal Microscopy
NOTE: The stained cells can be viewed after the coverslips have been allowed to cure overnight and have been sealed to the microscope slide with nail polish. Here, imaging using a confocal microscope is described. Cells can also be viewed by standard fluorescence microscopy.
<ol>
	<li>Place the slide with the untreated control cells on the microscope stage and focus the microscope on the cells.</li>
	<li>Using the microscope Look Up Table (LUT) settings, adjust the offset such that there is no positive FAM-YVAD-FMK staining in the untreated cells. This process can also be performed using caspase-1 deficient macrophages. 
	NOTE: The offset has to be adjusted for each channel used in the experiment, but setting the correct offset is most critical for the FAM-YVAD-FMK channel and fluorescent antibody channels. The offset for the DNA channel is less critical. Once the offset has been set, do not adjust this setting for the rest of the experiment.</li>
	<li>Switch the slide to the nigericin treated sample. Find a field that contains both cells that are positive and negative for FAM-YVAD-FMK staining. Adjust the imaging plane of the FAM-YVAD-FMK channel to the plane that has the highest intensity of positive staining. This will normally be the plane where the center of the inflammasome focus is imaged.</li>
	<li>Adjust the gain such that foci are visible in cells that have condensed nuclei. After setting both gain and offset, leave these settings for the rest of the imaging session. 
	NOTE: One easy way to determine if a cell is pyroptotic is by looking at nuclear morphology. Cells with active caspase-1 have rounded and condensed nuclei, while nucleoli are visible in cells without caspase-1 activation and the nuclear morphology is similar to those of untreated cells.</li>
	<li>Collect images of 5 randomly selected fields at 100X total magnification. This will normally result in about 40 cells per image. Repeat this process for each sample.</li>
	<li>Count the number of cells in each image using image analysis software. Then count the number of cells that have positive FAM-YVAD-FMK staining. Represent the level of caspase-1 activation as the percentage of FAM-YVAD-FMK positive cells.</li>
</ol>
7. LDH Release Assay
NOTE: For the LDH release assay, seed and prime the cells as described in the previous section, except use a 96 well plate. Do not remove the medium after priming.
<ol>
	<li>Add 50 &#956;L of DMEM-5 containing 10 &#956;M nigericin to the experimental wells and 50 &#956;L DMEM-5 to the spontaneous and 100% lysis control wells. Do not add glycine in this experiment since the goal is to measure cell lysis. Incubate for 60 min at 37 &#176;C and 5% CO2.</li>
	<li>After 30 min, add 10 &#956;L of 10x lysis buffer to the 100% lysis control wells and add 10 &#956;L of DMEM-5 to the other wells. During this incubation, remove 1 vial of substrate mix (1.5 mL of freeze-dried substrate) and 1 aliquot of assay buffer (~12 mL) from the freezer and let them thaw protected from light to room temperature. 
	NOTE: The substrate mix contains a tetrazolium salt (iodonitro-tetrazolium violet), which is converted to a red formazan product.</li>
	<li>After the 60 min total incubation, centrifuge the plate for 5 min at 500 x g at 10 &#176;C. Transfer 50 &#956;L of the supernatant to a clear flat-bottom plate. During this time, add 12 mL of assay buffer to the vial of substrate mix and incubate at room temperature for 5 min before using.</li>
	<li>Add 50 &#956;L of substrate to each well and incubate for 30 min in the dark. Include medium only wells for blank values. Check the plate after 15 min to make sure that the signal will not exceed the detection limit of the plate reader.</li>
	<li>After 30 min, add 50 &#956;L of stop solution (1 M acetic acid) and measure OD490 using a plate reader.</li>
	<li>Calculate the percentage of cell lysis using the following formula: 
	% Cytoxicity = ((Experimental - Spontaneous)/(Maximum - Spontaneous))&#215;100 
	Experimental: nigericin treated cells; spontaneous: untreated cells; maximum: cells exposed to lysis buffer</li>
</ol>

<ol><li>Jorgensen, I., Miao, E. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pyroptotic+cell+death+defends+against+intracellular+pathogens%5BTitle%5D)+AND+%22Immunol+Rev%22%5BJournal%5D)">Pyroptotic cell death defends against intracellular pathogens.</a> Immunol Rev. 265 (1), 130-142 (2015).</li>
<li>Guo, H., Callaway, J. B., Ting, J. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inflammasomes%3A+mechanism+of+action%2C+role+in+disease%2C+and+therapeutics%5BTitle%5D)+AND+%22Nat+Med%22%5BJournal%5D)">Inflammasomes: mechanism of action, role in disease, and therapeutics.</a> Nat Med. 21 (7), 677-687 (2015).</li>
<li>Bergsbaken, T., Fink, S. L., Cookson, B. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pyroptosis%3A+host+cell+death+and+inflammation%5BTitle%5D)+AND+%22Nat+Rev+Microbiol%22%5BJournal%5D)">Pyroptosis: host cell death and inflammation.</a> Nat Rev Microbiol. 7 (2), 99-109 (2009).</li>
<li>Martinon, F., Burns, K., Tschopp, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+inflammasome%3A+a+molecular+platform+triggering+activation+of+inflammatory+caspases+and+processing+of+proIL-beta%5BTitle%5D)+AND+%22Mol+Cell%22%5BJournal%5D)">The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.</a> Mol Cell. 10 (2), 417-426 (2002).</li>
<li>Fink, S. L., Cookson, B. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Caspase-1-dependent+pore+formation+during+pyroptosis+leads+to+osmotic+lysis+of+infected+host+macrophages%5BTitle%5D)+AND+%22Cell+Microbiol%22%5BJournal%5D)">Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages.</a> Cell Microbiol. 8 (11), 1812-1825 (2006).</li>
<li>Bergsbaken, T., Fink, S. L., den Hartigh, A. B., Loomis, W. P., Cookson, B. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Coordinated+host+responses+during+pyroptosis%3A+caspase-1-dependent+lysosome+exocytosis+and+inflammatory+cytokine+maturation%5BTitle%5D)+AND+%22J+Immunol%22%5BJournal%5D)">Coordinated host responses during pyroptosis: caspase-1-dependent lysosome exocytosis and inflammatory cytokine maturation.</a> J Immunol. 187 (5), 2748-2754 (2011).</li>
<li>Shi, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cleavage+of+GSDMD+by+inflammatory+caspases+determines+pyroptotic+cell+death%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.</a> Nature. 526 (7575), 660-665 (2015).</li>
<li>Sutterwala, F. S., Haasken, S., Cassel, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanism+of+NLRP3+inflammasome+activation%5BTitle%5D)+AND+%22Ann+N+Y+Acad+Sci%22%5BJournal%5D)">Mechanism of NLRP3 inflammasome activation.</a> Ann N Y Acad Sci. 1319, 82-95 (2014).</li>
<li>Juliana, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Non-transcriptional+priming+and+deubiquitination+regulate+NLRP3+inflammasome+activation%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.</a> J Biol Chem. 287 (43), 36617-36622 (2012).</li>
<li>Py, B. F., Kim, M. S., Vakifahmetoglu-Norberg, H., Yuan, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deubiquitination+of+NLRP3+by+BRCC3+critically+regulates+inflammasome+activity%5BTitle%5D)+AND+%22Mol+Cell%22%5BJournal%5D)">Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.</a> Mol Cell. 49 (2), 331-338 (2013).</li>
<li>Song, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((NLRP3+Phosphorylation+Is+an+Essential+Priming+Event+for+Inflammasome+Activation%5BTitle%5D)+AND+%22Mol+Cell%22%5BJournal%5D)">NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation.</a> Mol Cell. 68 (1), 185-197 (2017).</li>
<li>Stutz, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((NLRP3+inflammasome+assembly+is+regulated+by+phosphorylation+of+the+pyrin+domain%5BTitle%5D)+AND+%22J+Exp+Med%22%5BJournal%5D)">NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.</a> J Exp Med. 214 (6), 1725-1736 (2017).</li>
<li>Broz, P., Dixit, V. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inflammasomes%3A+mechanism+of+assembly%2C+regulation+and+signalling%5BTitle%5D)+AND+%22Nat+Rev+Immunol%22%5BJournal%5D)">Inflammasomes: mechanism of assembly, regulation and signalling.</a> Nat Rev Immunol. 16 (7), 407-420 (2016).</li>
<li>Masumoto, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((ASC%2C+a+novel+22-kDa+protein%2C+aggregates+during+apoptosis+of+human+promyelocytic+leukemia+HL-60+cells%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells.</a> J Biol Chem. 274 (48), 33835-33838 (1999).</li>
<li>Yamamoto, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((ASC+is+essential+for+LPS-induced+activation+of+procaspase-1+independently+of+TLR-associated+signal+adaptor+molecules%5BTitle%5D)+AND+%22Genes+Cells%22%5BJournal%5D)">ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules.</a> Genes Cells. 9 (11), 1055-1067 (2004).</li>
<li>Miao, E. A., Rajan, J. V., Aderem, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Caspase-1-induced+pyroptotic+cell+death%5BTitle%5D)+AND+%22Immunol+Rev%22%5BJournal%5D)">Caspase-1-induced pyroptotic cell death.</a> Immunol Rev. 243 (1), 206-214 (2011).</li>
<li>LaRock, C. N., Cookson, B. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+Yersinia+virulence+effector+YopM+binds+caspase-1+to+arrest+inflammasome+assembly+and+processing%5BTitle%5D)+AND+%22Cell+Host+Microbe%22%5BJournal%5D)">The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing.</a> Cell Host Microbe. 12 (6), 799-805 (2012).</li>
<li>Swanson, M. S., Isberg, R. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Association+of+Legionella+pneumophila+with+the+macrophage+endoplasmic+reticulum%5BTitle%5D)+AND+%22Infect+Immun%22%5BJournal%5D)">Association of Legionella pneumophila with the macrophage endoplasmic reticulum.</a> Infect Immun. 63 (9), 3609-3620 (1995).</li>
<li>Miller, S. I., Ernst, R. K., Bader, M. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((LPS%2C+TLR4+and+infectious+disease+diversity%5BTitle%5D)+AND+%22Nat+Rev+Microbiol%22%5BJournal%5D)">LPS, TLR4 and infectious disease diversity.</a> Nat Rev Microbiol. 3 (1), 36-46 (2005).</li>
<li>Sester, D. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+novel+flow+cytometric+method+to+assess+inflammasome+formation%5BTitle%5D)+AND+%22J+Immunol%22%5BJournal%5D)">A novel flow cytometric method to assess inflammasome formation.</a> J Immunol. 194 (1), 455-462 (2015).</li>
<li>Sester, D. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessment+of+Inflammasome+Formation+by+Flow+Cytometry%5BTitle%5D)+AND+%22Curr+Protoc+Immunol%22%5BJournal%5D)">Assessment of Inflammasome Formation by Flow Cytometry.</a> Curr Protoc Immunol. , (2016).</li>
<li>DiPeso, L., Ji, D. X., Vance, R. E., Price, J. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cell+death+and+cell+lysis+are+separable+events+during+pyroptosis%5BTitle%5D)+AND+%22Cell+Death+Discov%22%5BJournal%5D)">Cell death and cell lysis are separable events during pyroptosis.</a> Cell Death Discov. , (2017).</li>
<li>Russo, H. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Active+Caspase-1+Induces+Plasma+Membrane+Pores+That+Precede+Pyroptotic+Lysis+and+Are+Blocked+by+Lanthanides%5BTitle%5D)+AND+%22J+Immunol%22%5BJournal%5D)">Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides.</a> J Immunol. 197 (4), 1353-1367 (2016).</li>
<li>Evavold, C. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+Pore-Forming+Protein+Gasdermin+D+Regulates+Interleukin-1+Secretion+from+Living+Macrophages%5BTitle%5D)+AND+%22Immunity%22%5BJournal%5D)">The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages.</a> Immunity. , (2017).</li>
</ol>

The authors have no conflicts of interest to disclose

In this manuscript, we have presented two techniques to examine inflammasome activation and the consequence of caspase-1 activation following NLRP3 stimulation in murine bone marrow-derived macrophages. The first technique allows the researcher to determine the level of caspase-1 activation on a cellular basis using the fluorescent reporter FAM-YVAD-FMK. This reporter is highly specific for binding the caspase-1 family of enzymes, as seen by the absence of staining in caspase-1/11 deficient macrophages. Specificity was a...

Inflammasome-mediated inflammation is a critical component of the defense against pathogenic organisms1, but also underlies the etiology of many diseases2. The inflammatory response to a wide range of infections is triggered by cytosolic detection of pathogen associated molecular patterns (PAMPs) or damage associated molecular patterns (DAMPs). Pattern recognition receptors (PRR), including members of the NOD-like receptor (NLR) family, oligomerize upon the detection of these PAMPs and DAMPs. This triggers the formation of a multi-protein complex termed the inflammasome, which contains the PRR, the adaptor protein Apoptosis-associated speck-like protein containing a C-terminal caspase-recruitment domain (CARD) (ASC), and the pro-form of caspase-13,4. This complex allows proximity-induced auto-activation of caspase-1. Active caspase-1 then leads to a set of events that are characteristic of the inflammatory cell death pathway pyroptosis. These events include: the cleavage and release of the inflammatory cytokines IL-1&#946; and IL-18, lysosome exocytosis with release of lysosomal contents into the extracellular space, nuclear condensation, and gasdermin D cleavage. The released N-terminal domain of gasdermin D inserts into the plasma membrane, forming pores that cause plasma membrane rupture and release of inflammatory contents, in addition to taking away a protective niche for pathogen replication5,6,7.
Here, we focus on the well-studied NLRP3 inflammasome. The activation of the NLRP3 inflammasome occurs through a two-step process8. The first &#34;priming&#34; step occurs through the recognition by Toll-like receptors (TLR) of a microbial product. This is replicated in the laboratory setting by using LPS to stimulate TLR4. This stimulation upregulates NLRP3 and pro-IL-1&#946; through NF-kB signaling. Priming additionally licenses NLRP3 through non-transcriptional mechanisms by inducing its deubiquitination9,10 and phosphorylation or dephosphorylation of specific residues11,12.
The second signal for NLRP3 activation is thought to involve mitochondrial factors, reactive oxygen species, potassium efflux and calcium signaling, although a unifying mechanism for NLRP3 activation remains elusive8. Activated NLRP3 oligomerizes through interactions between its NACHT domains, and recruits ASC via binding of the pyrin (PYD) domains13. In each cell, these macromolecular complexes form a single microscopically visible focus. ASC was originally identified as a 22 KDa protein that forms a &#34;speck&#34; during the apoptosis of human leukemia cells, and named apoptosis-associated speck-like protein containing a CARD14. It was later determined that ASC recruits pro-caspase-1 through the interaction of the CARD of ASC with the CARD of pro-caspase-1, forming the inflammasome15.
Not all NLRs require the presence of ASC to induce caspase-1 activation. Unlike NLRP3, NLRC4 and NLRP1b have CARD domains and can directly recruit pro-caspase-1 via CARD-CARD interactions to induce caspase-1 activation. In the absence of ASC, active caspase-1 remains diffuse throughout the cytosol and does not form a single focus. This diffuse active caspase-1 is sufficient to induce pyroptotic cell death, but is unable to process pro-IL-1&#946;13,16.
In this manuscript, we will discuss two ways to assess inflammasome activation. The first uses the fluorescent activity probe, FAM-YVAD-FMK, which binds the caspase-1 family of proteases. This family includes caspase-1, but also mouse caspase-11 and human caspase-4 and caspase-5. By using macrophages from caspase-1/11 deficient mice in all experiments, the specificity of this probe will be addressed. This method can be combined with antibody labeling of inflammasome components, which we will also describe. Microscopic visualization allows for the identification of individual cells containing active caspase-1 and oligomerized ASC. Using this method, researchers will be able to determine where in the inflammasome formation cascade their manipulations of the host cell or the pathogenic organism under study have an effect. For example, one can distinguish whether a given intervention prevents the recruitment of ASC to the NLRP3 complex or targets the subsequent recruitment and activation of caspase-117. Examining outcomes of caspase-1 activation such as IL-1&#946; secretion would not be able to distinguish between these two possibilities. Also, the secretion of IL-1&#946; could be altered without altering the cells ability to activate caspase-1 and undergo pyroptotic cell death16.
The second method measures the release of lactate dehydrogenase (LDH) into the cell supernatant, which occurs during pyroptotic macrophage lysis following caspase-1 activation as described above. This second method is a population-based approach as the release of LDH in the entire well is measured. This simple approach allows for the rapid analysis (30 min of incubation time) of samples to determine if there is caspase-1-mediated cell death and can be performed in a 96-well plate format.
These methods are complementary, each with different advantages, and both are easily amenable to modifications. For example, macrophage treatment with targeted small molecular weight compounds prior to inflammasome stimulation can be used to investigate the role certain proteins may have on controlling inflammatory responses.

<table><tbody><tr><td>E-MEM</td><td>ATCC</td><td>30-2003</td><td>For growing L929 cells</td></tr><tr><td>NCRC clone 929 (L929)</td><td>ATCC</td><td>CCL-1</td><td></td></tr><tr><td>Fixation/Permeabilization Kit</td><td>BD Biosciences</td><td>554714</td><td>Includes fixation and permeabilization solution, and wash buffer. Proprietary formulations. Contains 4.2% formaldehyde</td></tr><tr><td>Glycine</td><td>Biorad</td><td>161-0718</td><td></td></tr><tr><td>Cytotox96 Nonradioactive cytotoxicity assay</td><td>Fisher Scientific</td><td>PR-G1780</td><td>Includes Substrate Mix and Assay Buffer; Proprietary formulations. Stop solution is 1 M Acetic acid</td></tr><tr><td>FAM-YVAD-FMK</td><td>Immunocytochemistry Technologies</td><td>98</td><td></td></tr><tr><td>DMEM, high glucose, no glutamine</td><td>Invitrogen</td><td>11960044</td><td></td></tr><tr><td>DMEM, high glucose, no glutamine, no phenol red</td><td>Invitrogen</td><td>31053028</td><td></td></tr><tr><td>Dulbecco&#039;s PBS, no calcium, no magnesium</td><td>Invitrogen</td><td>14190144</td><td></td></tr><tr><td>Fetal Bovine Serum, qualified, US origin</td><td>Invitrogen</td><td>26140079</td><td>Heat inactivated at 55&amp;deg;C for 50 min</td></tr><tr><td>Gentamicin</td><td>Invitrogen</td><td>15750060</td><td></td></tr><tr><td>ProLong Gold Mounting Medium</td><td>Invitrogen</td><td>p36934</td><td>Proprietary formulation. Curing mounting medium. Hardens to refractory index of 1.46</td></tr><tr><td>goat anti-mouse ALEXA555</td><td>Invitrogen</td><td>A-21422</td><td></td></tr><tr><td>HEPES (Ultra Pure)</td><td>Invitrogen</td><td>11344041</td><td></td></tr><tr><td>L-Glutamine</td><td>Invitrogen</td><td>21051024</td><td></td></tr><tr><td>Penicillin-Streptomycin</td><td>Invitrogen</td><td>15140122</td><td></td></tr><tr><td>TO-PRO-3 Iodide</td><td>Invitrogen</td><td>T3605</td><td>far-red fluorescent nucleic acid stain</td></tr><tr><td>C57BL/6J mouse</td><td>Jackson Laboratoy</td><td>000664</td><td></td></tr><tr><td>caspase-1/11-/- mouse</td><td>Jackson Laboratory</td><td>016621</td><td></td></tr><tr><td>Leica SP8X Confocal Microscope</td><td>Leica</td><td></td><td></td></tr><tr><td>Ultrapure LPS from Salmonella minnesota R595 (Re)</td><td>List Biologicals</td><td>434</td><td></td></tr><tr><td>anti-ASC clone 2EI-7</td><td>Millipore-Sigma</td><td>04-417</td><td></td></tr><tr><td>beta-mercapto-ethanol</td><td>Millipore-Sigma</td><td>M6250-10ML</td><td></td></tr><tr><td>DMSO</td><td>Millipore-Sigma</td><td>D2650-5X10ML</td><td></td></tr><tr><td>EDTA</td><td>Millipore-Sigma</td><td>E5391</td><td></td></tr><tr><td>Spectramax M3 plate reader</td><td>Molecular Devices</td><td>5000414</td><td></td></tr></tbody></table>

detection of inflammasome activation and pyroptotic cell death in murine bone marrow-derived macrophages

Inflammasomes are innate immune signaling platforms that are required for the successful control of many pathogenic organisms, but also promote inflammatory and autoinflammatory diseases. Inflammasomes are activated by cytosolic pattern recognition receptors, including members of the NOD-like receptor (NLR) family. These receptors oligomerize upon the detection of microbial or damage-associated stimuli. Subsequent recruitment of the adaptor protein ASC forms a microscopically visible inflammasome complex, which activates caspase-1 through proximity-induced auto-activation. Following the activation, caspase-1 cleaves pro-IL-1&#946; and pro-IL-18, leading to the activation and secretion of these pro-inflammatory cytokines. Caspase-1 also mediates the inflammatory form of cell death termed pyroptosis, which features the loss of membrane integrity and cell lysis. Caspase-1 cleaves gasdermin D, releasing the N-terminal fragment which forms plasma membrane pores, leading to osmotic lysis.
In vitro, the activation of caspase-1 can be determined by labeling bone marrow-derived macrophages with the caspase-1 activity probe FAM-YVAD-FMK and by labeling the cells with antibodies against the adaptor protein ASC. This technique allows the identification of inflammasome formation and caspase-1 activation in individual cells using fluorescence microscopy. Pyroptotic cell death can be detected by measuring the release of cytosolic lactate dehydrogenase into the medium. This procedure is simple, cost effective and performed in a 96-well plate format, allowing adaptation for screening. In this manuscript, we show that activation of the NLRP3 inflammasome by nigericin leads to the co-localization of the adaptor protein ASC and active caspase-1, leading to pyroptosis.

To detect caspase-1 activation following the exposure to nigericin, the cells were processed as described in the protocol section. We combined both FAM-YVAD-FMK and ASC antibody labeling in order to show that ASC and active caspase-1 co-localize following NLRP3-mediated inflammasome activation. Figure 1A shows that wild type macrophages exposed to 5 &#956;M nigericin have formation of an ASC focus in the perinuclear region. These foci also contain active casp...

Watch this Scientific Journal Video about Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages at JoVE.com

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

We describe the detection of NLRP3 inflammasome activation on cellular basis using fluorescence microscopy and staining for active caspase-1 and the adaptor, ASC. A lactate dehydrogenase release assay is presented to detect pyroptotic lysis on a population basis. These techniques can be adapted to study many aspects of inflammasome biology.

Inflammasomes are innate immune signaling platforms that are required for the successful control of many pathogenic organisms, but also promote ...

detection-inflammasome-activation-pyroptotic-cell-death-murine-bone

Microsoft Bing

Research

JoVE Journal

Immunology and Infection

10.7K Views.  University of Washington. We describe the detection of NLRP3 inflammasome activation on cellular basis using fluorescence microscopy and staining for active caspase-1 and the adaptor, ASC. A lactate dehydrogenase release assay is presented to detect pyroptotic lysis on a population basis. These techniques can be adapted to study many aspects of inflammasome biology.

Video: Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

The article describes a readily easy adaptive in vitro model to investigate macrophage polarization. In the presence of GM-CSF/M-CSF, hematopoietic stem/progenitor cells from the bone marrow are directed into monocytic differentiation, followed by M1 or M2 stimulation. The activation status can be tracked by changes in cell surface antigens, gene expression and cell signaling pathways.

The article describes a readily easy adaptive in vitro model to investigate macrophage polarization. In the presence of GM-CSF/M-CSF, hematopoietic stem/progenitor cells from the bone marrow are directed into monocytic differentiation, followed by M1 or M2 stimulation. The activation status can be tracked by changes in cell surface antigens, gene expression and cell signaling pathways.

The article describes a readily easy adaptive in vitro model to investigate macrophage polarization. In the presence of GM-CSF/M-CSF, hematopoietic ...

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells

Inflammatory processes resulting from the secretion of Interleukin (IL)-1 family cytokines by immune cells lead to local or systemic inflammation, tissue remodeling and repair, and virologic control1,2 . Interleukin-1&#946; is an essential element of the innate immune response and contributes to eliminate invading pathogens while preventing the establishment of persistent infection1-5.
Inflammasomes are the key signaling platform for the activation of interleukin 1 converting enzyme (ICE or Caspase-1). The NLRP3 inflammasome requires at least two signals in DCs to cause IL-1&#946; secretion6. Pro-IL-1&#946; protein expression is limited in resting cells; therefore a priming signal is required for IL-1&#946; transcription and protein expression. A second signal sensed by NLRP3 results in the formation of the multi-protein NLRP3 inflammasome. The ability of dendritic cells to respond to the signals required for IL-1&#946; secretion can be tested using a synthetic purine, R848, which is sensed by TLR8 in human monocyte derived dendritic cells&#160;(moDCs) to prime cells, followed by activation of the NLRP3 inflammasome with the bacterial toxin and potassium ionophore, nigericin.
Monocyte derived DCs&#160;are easily produced in culture and provide significantly more cells than purified human myeloid DCs. The method presented here differs from other inflammasome assays in that it uses in vitro human, instead of mouse derived, DCs thus allowing for the study of the inflammasome in human disease and infection.

Dendritic cells (DCs)&#160;secrete IL-1&#946; in response to TLR8 recognition of synthetic purine, R848, followed by NLRP3 inflammasome activation with nigericin, therefore, IL-1&#946; can be used to measure NLRP3 inflammasome activity. Intracellular cytokine staining, immunoblotting, and ELISA are used to accurately measure NLRP3 inflammasome priming and activation via IL-1&#946; expression.

Inflammatory processes resulting from the secretion of Interleukin (IL)-1 family cytokines by immune cells lead to local or systemic inflammation, tissue ...

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Macrophages, as key players of the innate immune response, are at the focus of research dealing with tissue homeostasis or various pathologies. Transfection with siRNA and plasmid DNA is an efficient tool for studying their function, but transfection of macrophages is not a trivial matter. Although many different approaches for transfection of eukaryotic cells are available, only few allow reliable and efficient transfection of macrophages, but reduced cell vitality and severely altered cell behavior like diminished capability for differentiation or polarization are frequently observed. Therefore a transfection protocol is required that is capable of transferring siRNA and plasmid DNA into macrophages without causing serious side-effects thus allowing the investigation of the effect of the siRNA or plasmid in the context of normal cell behavior. The protocol presented here provides a method for reliably and efficiently transfecting human THP-1 macrophages and monocytes with high cell vitality, high transfection efficiency, and minimal effects on cell behavior. This approach is based on Nucleofection and the protocol has been optimized to maintain maximum capability for cell activation after transfection. The protocol is adequate for adherent cells after detachment as well as cells in suspension, and can be used for small to medium sample numbers. Thus, the method presented is useful for investigating gene regulatory effects during macrophage differentiation and polarization. Apart from presenting results characterizing macrophages transfected according to this protocol in comparison to an alternative chemical method, the impact of cell culture medium selection after transfection on cell behavior is also discussed. The presented data indicate the importance of validating the selection for different experimental settings.

This protocol presents an efficient and reliable method to transfect human THP-1 macrophages with siRNA or plasmid DNA by electroporation with high transfection efficiency while maintaining high cell vitality and full macrophage capacity for differentiation and polarization.

Macrophages, as key players of the innate immune response, are at the focus of research dealing with tissue homeostasis or various pathologies. ...

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

The persistent inflammatory host response to an implanted biomaterial, known as the foreign body reaction, is a significant challenge in the development and implementation of biomedical devices and tissue engineering constructs. Macrophages, an innate immune cell, are key players in the foreign body reaction because they remain at the implant site for the lifetime of the device, and are commonly studied to gain an understanding of this detrimental host response. Many biomaterials researchers have shown that adsorbed protein layers on implanted materials influence macrophage behavior, and subsequently impact the host response. The methods in this paper describe an in vitro model using adsorbed protein layers containing cellular damage molecules on polymer biomaterial surfaces to assess macrophage responses. An NF-&#1082;B/AP-1 reporter macrophage cell line and the associated colorimetric alkaline phosphatase assay were used as a rapid method to indirectly examine NF-&#1082;B/AP-1 transcription factor activity in response to complex adsorbed protein layers containing blood proteins and damage-associated molecular patterns, as a model of the complex adsorbed protein layers formed on biomaterial surfaces in vivo.

This protocol provides researchers with a rapid, indirect method of measuring TLR-dependent NF-&#1082;B/AP-1 transcription factor activity in a murine macrophage cell line in response to a variety of polymeric surfaces and adsorbed protein layers that model the biomaterial implant microenvironment.

The persistent inflammatory host response to an implanted biomaterial, known as the foreign body reaction, is a significant challenge in the development ...

Bioengineering

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Inflammatory caspases include caspase-1, -4, -5, -11, and -12 and belong to the subgroup of initiator caspases. Caspase-1 is required to ensure correct regulation of inflammatory signaling and is activated by proximity-induced dimerization following recruitment to inflammasomes. Caspase-1 is abundant in the monocytic cell lineage and induces maturation of the pro-inflammatory cytokines interleukin (IL)-1&#946; and IL-18 to active secreted molecules. The other inflammatory caspases, caspase-4 and -5 (and their murine homolog caspase-11) promote IL-1&#946; release by inducing pyroptosis. Caspase Bimolecular Fluorescence Complementation (BiFC) is a tool used to measure inflammatory caspase induced proximity as a readout of caspase activation. The caspase-1, -4, or -5 prodomain, which contains the region that binds to the inflammasome, is fused to non-fluorescent fragments of the yellow fluorescent protein Venus (Venus-N [VN] or Venus-C [VC]) that associate to reform the fluorescent Venus complex when the caspases undergo induced proximity. This protocol describes how to introduce these reporters into primary human monocyte-derived macrophages (MDM) using nucleofection, treat the cells to induce inflammatory caspase activation, and measure caspase activation using fluorescence and confocal microscopy. The advantage of this approach is that it can be used to identify the components, requirements, and localization of the inflammatory caspase activation complex in living cells. However, careful controls need to be considered to avoid compromising cell viability and behavior. This technique is a powerful tool for the analysis of dynamic caspase interactions at the inflammasome level as well as for the interrogation of the inflammatory signaling cascades in living MDM and monocytes derived from human blood samples.

This protocol describes the workflow to obtain monocytes-derived macrophages (MDM) from human blood samples, a simple method to efficiently introduce inflammatory caspase Bimolecular Fluorescence Complementation (BiFC) reporters into human MDM without compromising cell viability and behavior, and an imaging-based approach to measure inflammatory caspase activation in living cells.

Inflammatory caspases include caspase-1, -4, -5, -11, and -12 and belong to the subgroup of initiator caspases. Caspase-1 is required to ensure correct ...

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Innate immunity provides the critical first line of defense in response to pathogens and sterile insults. A key mechanistic component of this response is the initiation of innate immune programmed cell death (PCD) to eliminate infected or damaged cells and propagate immune responses. However, excess PCD is associated with inflammation and pathology. Therefore, understanding the activation and regulation of PCD is a central aspect of characterizing innate immune responses and identifying new therapeutic targets across the disease spectrum.
This protocol provides methods for characterizing innate immune PCD activation by monitoring caspases, a family of cysteine-dependent proteases that are often associated with diverse PCD pathways, including&#160;apoptosis,&#160;pyroptosis, necroptosis, and PANoptosis. Initial reports characterized caspase-2, caspase-8, caspase-9, and caspase-10 as initiator caspases and caspase-3, caspase-6, and caspase-7 as effector caspases in apoptosis, while later studies found the inflammatory caspases, caspase-1, caspase-4, caspase-5, and caspase-11, drive pyroptosis. It is now known that there is extensive crosstalk between the caspases and other innate immune and&#160;cell death molecules across the previously defined PCD pathways, identifying a key knowledge gap in the mechanistic understanding of innate immunity and PCD and&#160;leading to the characterization of PANoptosis. PANoptosis is a unique innate immune inflammatory PCD pathway regulated by PANoptosome complexes, which integrate components, including caspases,&#160;from other cell death pathways.
Here, methods for assessing the activation of caspases in response to various stimuli are provided. These methods allow for the characterization of PCD pathways both in vitro and in vivo, as activated caspases undergo proteolytic cleavage that can be visualized by western blotting using optimal antibodies and blotting conditions. A protocol and western blotting workflow have been established that allow for the assessment of the activation of multiple caspases from the same cellular population, providing a comprehensive characterization of the PCD processes. This method can be applied across research areas in development, homeostasis, infection, inflammation, and cancer to evaluate PCD pathways throughout cellular processes in health and disease.

This protocol describes a comprehensive method for assessing caspase activation (caspase-1, caspase-3, caspase-7, caspase-8, caspase-9, and caspase-11) in response to both in vitro and in vivo (in mice) models of infection, sterile insults, and cancer to determine the initiation of cell death pathways, such as pyroptosis, apoptosis, necroptosis, and PANoptosis.

Innate immunity provides the critical first line of defense in response to pathogens and sterile insults. A key mechanistic component of this response is ...

Activation of Mouse Bone Marrow-Derived Macrophages in Response to Antibodies

Source: Kozicky, L. et al., <a href="https://app.jove.com/v/56689">Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation.</a> J. Vis. Exp. (2017)
In this video, we demonstrate the activation of bone marrow-derived macrophages in response to bacterial lipopolysaccharide and intravenous immunoglobulin.

Aktywacja makrofagów pochodzących ze szpiku kostnego myszy w odpowiedzi na przeciwciała

Source: Kozicky, L. et al., Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation. J. Vis. Exp. (2017)
In ...

JoVE Encyclopedia of Experiments

Immunology

Immune Response

Host Defense Mechanism

Detection of Inflammasome Activation via Fluorescence Microscopy

Source: den Hartigh, A. B. et al., <a href="https://app.jove.com/v/57463">Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages.</a> J. Vis. Exp.&#160;(2018)
This video demonstrates a method to detect NLRP3 inflammasome activation in macrophages using fluorescent reporter probes. The cells are treated with potassium ionophores and glycine to induce inflammasome assembly and caspase-1 activation. Fluorescent reporter probes visualize activated caspase-1, and cells are stained with a fluorescent dye for nuclei visualization.

Wykrywanie aktywacji inflamasomu za pomocą mikroskopii fluorescencyjnej

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board.
1. ...

An In Vitro Technique to Study Inflammasome Complex Formation in Macrophages

Source: den Hartigh, A. B., et al. <a href="https://app.jove.com/v/57463">Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages.</a> J. Vis. Exp. (2018).
This video demonstrates a technique to study NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome formation in primary macrophages via immunofluorescence. The macrophages are first primed with bacterial lipopolysaccharide (LPS) to upregulate NLRP3 protein expression. Exposing the macrophages to nigericin&#8212;a potassium ionophore&#8212;leads to the activation of NLRP3 and the formation of inflammasomes, which are visualized via immunofluorescence.

Technika in vitro do badania tworzenia kompleksów inflamasomów w makrofagach

A Lactate Dehydrogenase Release Assay To Detect Macrophage Death Following Nigericin Exposure

Source: den Hartigh, A.B. et al., <a href="https://app.jove.com/v/57463">Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages.</a> J. Vis. Exp. (2018)
This video demonstrates the lactate dehydrogenase assay to detect inflammasome-mediated macrophage death. The macrophages are exposed to lipopolysaccharide for priming, followed by exposure to nigericin to cause inflammasome-induced cell death, which is determined by the lactate dehydrogenase assay.

Test uwalniania dehydrogenazy mleczanowej w celu wykrycia śmierci makrofagów po ekspozycji na nigerycynę

1. LDH Release Assay
NOTE: For the LDH release assay, seed the cells in a 96-well plate. Do not remove the medium after priming.

	Replace the medium with ...